Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: To exam five-year overall survival (OS) of upper urinary tract urothelial carcinoma (UTUC) patients versus age- and sex-matched population-based controls.
Methods: Within Surveillance, Epidemiology, and End Results database (2004-2020), we identified newly diagnosed (2004-2015) UTUC patients. Relying on Social Security Administration Life Tables (2004-2020) age- and sex- matched population-based controls were simulated (Monte Carlo simulation).
Results: Of 10,140 UTUC patients, 3,984 (39%) exhibited localized, 4,904 (49%) locally advanced, and 1,252 (12%) metastatic stage. At five years of follow-up, the OS rate was 41 versus 78% (Δ 37%) in UTUC patients versus controls. According to stage, OS difference was greatest in metastatic stage (4 versus 75%; Δ 71%), followed by locally advanced (36 versus 78%; Δ 42%) and localized stage (58 versus 78%; Δ 20%). At five years of follow-up, CSM rate was 44% and OCM rate was 16%. According to stage, CSM and OCM rates were 88 and 7% in metastatic, 49 and 15% in locally advanced, and 22 and 19% in localized stage UTUC patients.
Conclusion: UTUC patients may experience worse OS compared to population-based controls. The most pronounced differences in five-year OS were recorded in metastatic and locally advanced stage, suggesting a potentially substantial impact of UTUC on patients' life expectancy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000548236 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinoma.
Urol Oncol
September 2025
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Objective: To examine differences in cancer-specific mortality (CSM) in nonmetastatic upper tract urothelial carcinoma (UTUC) patients with vs. without secondary bladder cancer (BCa) after radical nephroureterectomy (RNU).
Methods: Within the Surveillance, Epidemiology, and End Results database (SEER 2000-2021), T1-T4N0M0 UTUC patients treated with RNU and diagnosed with secondary BCa were identified.
Prognostic Implications of Postoperative Serum CYFRA Levels in Upper Tract Urothelial Carcinoma.
J Nippon Med Sch
September 2025
Department of Urology, Nippon Medical School.
Background: Current guidelines lack recommendations for serum tumor markers in patients with upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU). This study assessed the potential of the postoperative serum C-terminus of cytokeratin 19 (CYFRA21-1, CYFRA) level, hereafter referred to as poCY, as a predictor of early progression in patients treated with RNU.
Methods: Overall, 117 patients were categorized into the high group (HG) or low group (LG) based on a poCY cutoff level of 3.
High carbohydrate antigen 19-9 levels indicate poor prognosis in patients with bladder cancer following radical cystectomy.
Front Oncol
August 2025
Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea.
Introduction: Our team previously reported that elevated carbohydrate antigen (CA) 19-9 levels are associated with a worse prognosis in upper tract urothelial carcinoma (UTUC). Several studies have reported a correlation between high tumor burden and elevated CA19-9 levels in urothelial carcinomas. However, no studies have specifically examined the association between CA19-9 levels and outcomes of patients with bladder cancer who underwent radical cystectomy.
View Article and Find Full Text PDFRadical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registry.
World J Urol
September 2025
Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, 37126, Italy.
Purpose: Radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) in solitary kidney patients is a rare and underreported scenario. This study aims to compare the outcomes of UTUC solitary kidney patients becoming anephric after RNU to those of patients undergoing kidney-sparing surgery (KSS).
Methods: Data from patients with a solitary kidney were retrieved from the ROBUUST 2.
Purpose: To exam five-year overall survival (OS) of upper urinary tract urothelial carcinoma (UTUC) patients versus age- and sex-matched population-based controls.
Methods: Within Surveillance, Epidemiology, and End Results database (2004-2020), we identified newly diagnosed (2004-2015) UTUC patients. Relying on Social Security Administration Life Tables (2004-2020) age- and sex- matched population-based controls were simulated (Monte Carlo simulation).